BioTelemetry Stock Price, News & Analysis (NASDAQ:BEAT)

$28.30 0.55 (1.98 %)
(As of 12/13/2017 01:49 PM ET)
Previous Close$27.75
Today's Range$27.85 - $28.50
52-Week Range$20.65 - $39.20
Volume338,800 shs
Average Volume479,581 shs
Market Capitalization$899.33 million
P/E Ratio38.01
Dividend YieldN/A
Beta0.53

About BioTelemetry (NASDAQ:BEAT)

BioTelemetry logoBioTelemetry, Inc. (BioTelemetry), formerly CardioNet, Inc., provides cardiac monitoring services, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. The Company operates in three segments: patient services, product and research services. The patient services business segment's principal focus is on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders, through its core Mobile Cardiac Outpatient Telemetry(MCOT), event and Holter services in a healthcare setting. The product business segment focuses on the development, manufacturing, testing and marketing of medical devices to medical companies, clinics and hospitals. The Company's research services focuses on providing cardiac safety monitoring services for drug and medical treatment trials in a research environment. In August 2012, the Company completed the acquisition of Cardiocore Lab, Inc. (Cardiocore).

Receive BEAT News and Ratings via Email

Sign-up to receive the latest news and ratings for BEAT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Laboratories & Research
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:BEAT
CUSIPN/A
Phone610-729-7000

Debt

Debt-to-Equity Ratio0.75%
Current Ratio1.60%
Quick Ratio1.48%

Price-To-Earnings

Trailing P/E Ratio38.01
Forward P/E Ratio34.10
P/E Growth1.73

Sales & Book Value

Annual Sales$208.33 million
Price / Sales4.40
Cash Flow$1.40 per share
Price / Cash20.20
Book Value$4.92 per share
Price / Book5.75

Profitability

Trailing EPS$1.29
Net Income$53.43 million
Net Margins16.10%
Return on Equity13.66%
Return on Assets8.44%

Miscellaneous

Employees1,087
Outstanding Shares32,410,000

BioTelemetry (NASDAQ:BEAT) Frequently Asked Questions

What is BioTelemetry's stock symbol?

BioTelemetry trades on the NASDAQ under the ticker symbol "BEAT."

How were BioTelemetry's earnings last quarter?

BioTelemetry, Inc. (NASDAQ:BEAT) released its quarterly earnings results on Tuesday, November, 7th. The medical research company reported $0.16 earnings per share for the quarter, missing the consensus estimate of $0.25 by $0.09. The medical research company had revenue of $81.02 million for the quarter, compared to analysts' expectations of $82.10 million. BioTelemetry had a return on equity of 13.66% and a net margin of 16.10%. The business's quarterly revenue was up 52.7% on a year-over-year basis. During the same period in the previous year, the business posted $0.21 EPS. View BioTelemetry's Earnings History.

When will BioTelemetry make its next earnings announcement?

BioTelemetry is scheduled to release their next quarterly earnings announcement on Tuesday, February, 20th 2018. View Earnings Estimates for BioTelemetry.

Where is BioTelemetry's stock going? Where will BioTelemetry's stock price be in 2017?

8 analysts have issued twelve-month price objectives for BioTelemetry's shares. Their forecasts range from $37.00 to $50.00. On average, they expect BioTelemetry's share price to reach $43.50 in the next year. View Analyst Ratings for BioTelemetry.

Are investors shorting BioTelemetry?

BioTelemetry saw a increase in short interest in November. As of November 30th, there was short interest totalling 1,922,685 shares, an increase of 32.8% from the November 15th total of 1,447,612 shares. Based on an average daily volume of 516,370 shares, the days-to-cover ratio is presently 3.7 days. Currently, 6.1% of the shares of the stock are sold short.

Who are some of BioTelemetry's key competitors?

Who owns BioTelemetry stock?

BioTelemetry's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Bank of New York Mellon Corp (4.44%), Dimensional Fund Advisors LP (4.39%), Hood River Capital Management LLC (2.81%), Russell Investments Group Ltd. (2.69%), Thompson Siegel & Walmsley LLC (1.66%) and Pembroke Management LTD (1.39%). Company insiders that own BioTelemetry stock include Daniel Wisniewski, Fred Broadway, George Hrenko, Heather C Getz, Joseph H Capper, Peter Ferola and Robert J Rubin. View Institutional Ownership Trends for BioTelemetry.

Who sold BioTelemetry stock? Who is selling BioTelemetry stock?

BioTelemetry's stock was sold by a variety of institutional investors in the last quarter, including Allianz Asset Management GmbH, Monarch Partners Asset Management LLC, Ameriprise Financial Inc., Russell Investments Group Ltd., Argent Capital Management LLC, Cortina Asset Management LLC, Wells Fargo & Company MN and EAM Investors LLC. Company insiders that have sold BioTelemetry company stock in the last year include Fred Broadway, George Hrenko and Robert J Rubin. View Insider Buying and Selling for BioTelemetry.

Who bought BioTelemetry stock? Who is buying BioTelemetry stock?

BioTelemetry's stock was bought by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Pembroke Management LTD, Hood River Capital Management LLC, Thompson Siegel & Walmsley LLC, Stifel Financial Corp, Strs Ohio, Nicholas Investment Partners LP and Columbia Partners L L C Investment Management. View Insider Buying and Selling for BioTelemetry.

How do I buy BioTelemetry stock?

Shares of BioTelemetry can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is BioTelemetry's stock price today?

One share of BioTelemetry stock can currently be purchased for approximately $28.30.

How big of a company is BioTelemetry?

BioTelemetry has a market capitalization of $899.33 million and generates $208.33 million in revenue each year. The medical research company earns $53.43 million in net income (profit) each year or $1.29 on an earnings per share basis. BioTelemetry employs 1,087 workers across the globe.

How can I contact BioTelemetry?

BioTelemetry's mailing address is 1000 Cedar Hollow Road, Malvern PA, 19355. The medical research company can be reached via phone at 610-729-7000 or via email at [email protected]


MarketBeat Community Rating for BioTelemetry (BEAT)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  167 (Vote Outperform)
Underperform Votes:  138 (Vote Underperform)
Total Votes:  305
MarketBeat's community ratings are surveys of what our community members think about BioTelemetry and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

BioTelemetry (NASDAQ:BEAT) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.752.753.003.00
Ratings Breakdown: 1 Sell Rating(s)
0 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $43.50$43.50$45.75$28.25
Price Target Upside: 70.09% upside70.09% upside38.43% upside4.88% downside

BioTelemetry (NASDAQ:BEAT) Consensus Price Target History

Price Target History for BioTelemetry (NASDAQ:BEAT)

BioTelemetry (NASDAQ:BEAT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/8/2017Dougherty & CoReiterated RatingBuy$40.00N/AView Rating Details
10/26/2017Raymond James FinancialInitiated CoverageOutperform$37.00N/AView Rating Details
10/23/2017SunTrust BanksInitiated CoverageBuy$41.00N/AView Rating Details
9/15/2017Off Wall StreetInitiated CoverageSellMediumView Rating Details
8/10/2017SidotiReiterated RatingBuy$42.00 -> $49.00LowView Rating Details
7/19/2017BenchmarkBoost Price TargetBuy -> Buy$38.00 -> $44.00LowView Rating Details
7/14/2017Lake Street CapitalReiterated RatingBuy$35.00 -> $50.00HighView Rating Details
12/13/2016GabelliReiterated RatingBuyN/AView Rating Details
(Data available from 12/13/2015 forward)

Earnings

BioTelemetry (NASDAQ:BEAT) Earnings History and Estimates Chart

Earnings by Quarter for BioTelemetry (NASDAQ:BEAT)

BioTelemetry (NASDAQ BEAT) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/20/2018$0.23N/AView Earnings Details
11/7/2017Q3 2017$0.25$0.16$82.10 million$81.02 millionViewN/AView Earnings Details
8/8/2017Q2 2017$0.21$0.23$58.39 million$58.10 millionViewListenView Earnings Details
5/3/2017Q1 2017$0.14$0.16$55.11 million$55.88 millionViewListenView Earnings Details
2/22/2017Q4 2016$0.18$0.23$53.75 million$53.96 millionViewListenView Earnings Details
11/2/2016Q316$0.18$0.21$52.92 million$53.10 millionViewN/AView Earnings Details
8/2/2016Q2$0.17$0.20$50.27 million$52.68 millionViewListenView Earnings Details
4/26/2016Q1$0.10$0.20$46.54 million$48.60 millionViewListenView Earnings Details
2/17/2016Q415$0.11$0.15$45.89 million$46.70 millionViewListenView Earnings Details
11/9/2015Q3$0.11$0.13$46.05 million$43.49 millionViewN/AView Earnings Details
8/6/2015Q2$0.09$0.12$45.75 million$44.81 millionViewListenView Earnings Details
5/6/2015Q115$0.02$0.06$43.80 million$43.40 millionViewListenView Earnings Details
2/19/2015Q414$0.06$0.05$43.40 million$43.70 millionViewListenView Earnings Details
10/30/2014Q214$0.01$0.06$42.00 million$43.00 millionViewListenView Earnings Details
7/31/2014Q114$0.01$0.02$40.95 million$42.70 millionViewListenView Earnings Details
5/6/2014Q413($0.02)($0.04)$38.40 million$37.16 millionViewListenView Earnings Details
2/26/2014Q313($0.04)$0.05$32.26 million$33.10 millionViewListenView Earnings Details
11/5/2013($0.05)($0.12)$32.79 million$31.90 millionViewListenView Earnings Details
7/30/2013Q2 2013$0.02$27.50 million$32.10 millionViewListenView Earnings Details
2/13/2013Q4 2012($0.09)$26.80 million$30.00 millionViewListenView Earnings Details
11/5/2012Q312($0.09)($0.08)$26.49 million$27.00 millionViewN/AView Earnings Details
8/8/2012($0.04)($0.01)ViewN/AView Earnings Details
5/8/2012($0.12)($0.10)ViewN/AView Earnings Details
2/22/2012($0.13)($0.04)ViewN/AView Earnings Details
11/8/2011($0.09)($0.21)ViewN/AView Earnings Details
8/8/2011($0.06)($0.05)ViewN/AView Earnings Details
5/3/2011($0.15)($0.02)ViewN/AView Earnings Details
2/17/2011($0.16)($0.13)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

BioTelemetry (NASDAQ:BEAT) Earnings Estimates

2017 EPS Consensus Estimate: $0.85
2018 EPS Consensus Estimate: $1.06
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.20$0.20$0.20
Q2 20171$0.20$0.20$0.20
Q3 20173$0.18$0.27$0.21
Q4 20173$0.19$0.29$0.23
Q1 20181$0.22$0.22$0.22
Q2 20181$0.27$0.27$0.27
Q3 20181$0.28$0.28$0.28
Q4 20181$0.29$0.29$0.29
(Data provided by Zacks Investment Research)

Dividends

Dividend History for BioTelemetry (NASDAQ:BEAT)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

BioTelemetry (NASDAQ BEAT) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 9.60%
Institutional Ownership Percentage: 82.40%
Insider Trades by Quarter for BioTelemetry (NASDAQ:BEAT)
Institutional Ownership by Quarter for BioTelemetry (NASDAQ:BEAT)

BioTelemetry (NASDAQ BEAT) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/15/2017Robert J. RubinDirectorSell15,000$28.14$422,100.00View SEC Filing  
3/20/2017Fred BroadwaySVPSell3,429$26.90$92,240.10View SEC Filing  
2/27/2017George HrenkoSVPSell126,043$25.95$3,270,815.85View SEC Filing  
2/21/2017Fred BroadwaySVPSell8,070$24.81$200,216.70View SEC Filing  
9/19/2016George HrenkoSVPSell1,061$18.50$19,628.50View SEC Filing  
9/13/2016Heather C GetzCFOSell5,866$18.23$106,937.18View SEC Filing  
9/13/2016Joseph H CapperInsiderSell26,847$18.23$489,420.81View SEC Filing  
9/13/2016Peter FerolaGeneral CounselSell4,352$18.23$79,336.96View SEC Filing  
9/9/2016Fred BroadwaySVPSell3,146$17.84$56,124.64View SEC Filing  
9/8/2016George HrenkoSVPSell3,491$18.06$63,047.46View SEC Filing  
9/8/2016Heather C GetzCFOSell2,979$18.10$53,919.90View SEC Filing  
9/8/2016Joseph H CapperInsiderSell13,632$18.10$246,739.20View SEC Filing  
9/8/2016Peter FerolaGeneral CounselSell2,210$18.10$40,001.00View SEC Filing  
9/7/2016Daniel WisniewskiSVPSell9,225$18.51$170,754.75View SEC Filing  
9/7/2016Heather C GetzCFOSell18,945$18.52$350,861.40View SEC Filing  
9/7/2016Joseph H CapperInsiderSell86,681$18.52$1,605,332.12View SEC Filing  
9/7/2016Peter FerolaGeneral CounselSell14,053$18.52$260,261.56View SEC Filing  
9/6/2016Fred BroadwaySVPSell4,662$18.28$85,221.36View SEC Filing  
9/6/2016Heather C GetzCFOSell6,686$18.29$122,286.94View SEC Filing  
9/6/2016Joseph H CapperCEOSell30,595$18.29$559,582.55View SEC Filing  
9/6/2016Peter FerolaGeneral CounselSell4,960$18.29$90,718.40View SEC Filing  
9/2/2016Fred BroadwaySVPSell4,466$18.75$83,737.50View SEC Filing  
9/2/2016Heather C GetzCFOSell6,547$18.75$122,756.25View SEC Filing  
9/2/2016Joseph H CapperCEOSell29,953$18.75$561,618.75View SEC Filing  
9/2/2016Peter FerolaGeneral CounselSell4,856$18.75$91,050.00View SEC Filing  
9/1/2016Fred BroadwaySVPSell7,525$19.25$144,856.25View SEC Filing  
9/1/2016Heather C GetzCFOSell10,408$18.59$193,484.72View SEC Filing  
9/1/2016Joseph H CapperInsiderSell47,622$18.59$885,292.98View SEC Filing  
9/1/2016Peter FerolaGeneral CounselSell7,722$18.59$143,551.98View SEC Filing  
8/30/2016Fred BroadwaySVPSell12,121$19.07$231,147.47View SEC Filing  
8/30/2016Heather C GetzCFOSell17,482$19.07$333,381.74View SEC Filing  
8/30/2016Joseph H CapperInsiderSell79,986$19.07$1,525,333.02View SEC Filing  
8/30/2016Peter FerolaGeneral CounselSell12,970$19.07$247,337.90View SEC Filing  
8/25/2016Fred BroadwaySVPSell5,877$19.16$112,603.32View SEC Filing  
8/25/2016Heather C GetzCFOSell8,477$19.16$162,419.32View SEC Filing  
8/25/2016Joseph H CapperInsiderSell38,785$19.16$743,120.60View SEC Filing  
8/25/2016Peter FerolaGeneral CounselSell6,289$19.16$120,497.24View SEC Filing  
8/24/2016George HrenkoSVPSell7,473$20.11$150,282.03View SEC Filing  
8/24/2016Heather C GetzCFOSell8,778$20.11$176,525.58View SEC Filing  
8/24/2016Joseph H CapperCEOSell40,160$20.11$807,617.60View SEC Filing  
8/24/2016Peter FerolaGeneral CounselSell6,512$20.11$130,956.32View SEC Filing  
8/23/2016George HrenkoSVPSell3,165$20.67$65,420.55View SEC Filing  
8/23/2016Heather C GetzCFOSell3,717$20.67$76,830.39View SEC Filing  
8/23/2016Joseph H CapperCEOSell17,008$20.67$351,555.36View SEC Filing  
8/23/2016Peter FerolaGeneral CounselSell2,758$20.67$57,007.86View SEC Filing  
8/22/2016George HrenkoSVPSell4,149$20.85$86,506.65View SEC Filing  
8/22/2016Heather C GetzCFOSell4,874$20.85$101,622.90View SEC Filing  
8/22/2016Joseph H CapperCEOSell22,298$20.85$464,913.30View SEC Filing  
8/22/2016Peter FerolaGeneral CounselSell3,616$20.85$75,393.60View SEC Filing  
8/19/2016Daniel WisniewskiSVPSell9,025$20.96$189,164.00View SEC Filing  
8/19/2016Heather C GetzCFOSell9,026$20.96$189,184.96View SEC Filing  
8/19/2016Joseph H CapperInsiderSell9,049$20.96$189,667.04View SEC Filing  
8/19/2016Peter FerolaGeneral CounselSell9,035$20.96$189,373.60View SEC Filing  
5/9/2014Ronald AhrensDirectorBuy6,000$7.37$44,220.00View SEC Filing  
11/12/2013Ronald AhrensDirectorBuy5,000$11.73$58,650.00View SEC Filing  
11/12/2012Ronald A AhrensDirectorBuy15,000$2.22$33,300.00View SEC Filing  
9/5/2012Joseph H CapperCEOBuy23,540$2.25$52,965.00View SEC Filing  
8/31/2012Joseph H CapperCEOBuy2,600$2.28$5,928.00View SEC Filing  
8/29/2012Joseph H CapperCEOBuy10,800$2.30$24,840.00View SEC Filing  
8/28/2012Joseph H CapperCEOBuy1,300$2.19$2,847.00View SEC Filing  
8/27/2012Joseph H CapperCEOBuy1,600$2.12$3,392.00View SEC Filing  
8/23/2012Joseph H CapperCEOBuy9,600$2.08$19,968.00View SEC Filing  
8/20/2012Joseph H CapperCEOBuy14,160$1.97$27,895.20View SEC Filing  
8/17/2012Joseph H CapperCEOBuy9,800$2.10$20,580.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

BioTelemetry (NASDAQ BEAT) News Headlines

Source:
DateHeadline
Critical Comparison: BG Medicine (BGMD) vs. BioTelemetry (BEAT)Critical Comparison: BG Medicine (BGMD) vs. BioTelemetry (BEAT)
www.americanbankingnews.com - December 12 at 9:34 PM
Reviewing BG Medicine (BGMD) and BioTelemetry (BEAT)Reviewing BG Medicine (BGMD) and BioTelemetry (BEAT)
www.americanbankingnews.com - December 11 at 11:26 AM
Analyzing BG Medicine (BGMD) & BioTelemetry (BEAT)Analyzing BG Medicine (BGMD) & BioTelemetry (BEAT)
www.americanbankingnews.com - December 9 at 8:04 AM
Head to Head Analysis: BioTelemetry (BEAT) & Cannabis Science (CBIS)Head to Head Analysis: BioTelemetry (BEAT) & Cannabis Science (CBIS)
www.americanbankingnews.com - December 9 at 3:14 AM
Head-To-Head Analysis: BG Medicine (BGMD) vs. BioTelemetry (BEAT)Head-To-Head Analysis: BG Medicine (BGMD) vs. BioTelemetry (BEAT)
www.americanbankingnews.com - December 7 at 5:30 PM
BioTelemetry: Key Partnership In Apples Heart Study Featuring Apples Watch - Seeking AlphaBioTelemetry: Key Partnership In Apple's Heart Study Featuring Apple's Watch - Seeking Alpha
seekingalpha.com - December 7 at 9:54 AM
Reviewing BioTelemetry (BEAT) & BG Medicine (BGMD)Reviewing BioTelemetry (BEAT) & BG Medicine (BGMD)
www.americanbankingnews.com - December 5 at 7:52 PM
BioTelemetrys (BEAT) Telcare Unit Collaborates With Onduo - NasdaqBioTelemetry's (BEAT) Telcare Unit Collaborates With Onduo - Nasdaq
www.nasdaq.com - December 3 at 3:29 PM
Critical Review: BG Medicine (BGMD) & BioTelemetry (BEAT)Critical Review: BG Medicine (BGMD) & BioTelemetry (BEAT)
www.americanbankingnews.com - December 1 at 7:30 PM
BioTelemetrys (BEAT) Telcare Unit Collaborates With OnduoBioTelemetry's (BEAT) Telcare Unit Collaborates With Onduo
finance.yahoo.com - December 1 at 1:03 PM
BioTelemetry Ties Up With Apple, Grows in Cardiac MonitoringBioTelemetry Ties Up With Apple, Grows in Cardiac Monitoring
finance.yahoo.com - December 1 at 1:03 PM
BioTelemetry's (BEAT) Telcare Unit Collaborates With OnduoBioTelemetry's (BEAT) Telcare Unit Collaborates With Onduo
finance.yahoo.com - December 1 at 1:03 PM
BioTelemetry, Inc. (BEAT) Given Consensus Rating of "Buy" by BrokeragesBioTelemetry, Inc. (BEAT) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - November 30 at 4:04 PM
Apple Doesn't Need Next Big Thing For A While, Analyst SaysApple Doesn't Need Next Big Thing For A While, Analyst Says
finance.yahoo.com - November 30 at 3:29 PM
BioTelemetry, Inc. Enters Agreement to Provide Cardiac Monitoring for Apple’s Heart StudyBioTelemetry, Inc. Enters Agreement to Provide Cardiac Monitoring for Apple’s Heart Study
finance.yahoo.com - November 30 at 10:01 AM
Critical Survey: BG Medicine (BGMD) versus BioTelemetry (BEAT)Critical Survey: BG Medicine (BGMD) versus BioTelemetry (BEAT)
www.americanbankingnews.com - November 29 at 9:08 AM
BIIB & ALKS Team Up For MS Drug, REGNs Eylea Combo Fails Again, AEZS RisesBIIB & ALKS Team Up For MS Drug, REGN's Eylea Combo Fails Again, AEZS Rises
www.rttnews.com - November 28 at 9:04 AM
Analyzing BG Medicine (BGMD) and BioTelemetry (BEAT)Analyzing BG Medicine (BGMD) and BioTelemetry (BEAT)
www.americanbankingnews.com - November 28 at 7:44 AM
Head-To-Head Survey: BG Medicine (BGMD) & BioTelemetry (BEAT)Head-To-Head Survey: BG Medicine (BGMD) & BioTelemetry (BEAT)
www.americanbankingnews.com - November 27 at 5:56 AM
Financial Survey: BG Medicine (BGMD) and BioTelemetry (BEAT)Financial Survey: BG Medicine (BGMD) and BioTelemetry (BEAT)
www.americanbankingnews.com - November 26 at 9:24 AM
BG Medicine (BGMD) vs. BioTelemetry (BEAT) Head-To-Head AnalysisBG Medicine (BGMD) vs. BioTelemetry (BEAT) Head-To-Head Analysis
www.americanbankingnews.com - November 21 at 11:28 PM
Comparing Cannabis Science (CBIS) & BioTelemetry (BEAT)Comparing Cannabis Science (CBIS) & BioTelemetry (BEAT)
www.americanbankingnews.com - November 21 at 7:33 PM
Dougherty & Co Equities Analysts Lower Earnings Estimates for BioTelemetry, Inc. (BEAT)Dougherty & Co Equities Analysts Lower Earnings Estimates for BioTelemetry, Inc. (BEAT)
www.americanbankingnews.com - November 21 at 3:28 PM
Head-To-Head Contrast: BioTelemetry (BEAT) vs. Cannabis Science (CBIS)Head-To-Head Contrast: BioTelemetry (BEAT) vs. Cannabis Science (CBIS)
www.americanbankingnews.com - November 18 at 11:32 PM
$0.21 Earnings Per Share Expected for BioTelemetry, Inc. (BEAT) This Quarter$0.21 Earnings Per Share Expected for BioTelemetry, Inc. (BEAT) This Quarter
www.americanbankingnews.com - November 16 at 3:10 AM
BG Medicine (BGMD) & BioTelemetry (BEAT) Financial ReviewBG Medicine (BGMD) & BioTelemetry (BEAT) Financial Review
www.americanbankingnews.com - November 15 at 5:27 PM
Analysts Set Expectations for BioTelemetry, Inc.s FY2017 Earnings (BEAT)Analysts Set Expectations for BioTelemetry, Inc.'s FY2017 Earnings (BEAT)
www.americanbankingnews.com - November 15 at 7:32 AM
Oversold Conditions For BioTelemetry (BEAT)Oversold Conditions For BioTelemetry (BEAT)
www.thestreet.com - November 14 at 4:56 PM
BioTelemetry (BEAT) Q3 Earnings Miss, Revenues Meet Estimates - NasdaqBioTelemetry (BEAT) Q3 Earnings Miss, Revenues Meet Estimates - Nasdaq
www.nasdaq.com - November 14 at 1:25 AM
Head-To-Head Survey: BioTelemetry (BEAT) & Cannabis Science (CBIS)Head-To-Head Survey: BioTelemetry (BEAT) & Cannabis Science (CBIS)
www.americanbankingnews.com - November 13 at 5:38 AM
FY2017 EPS Estimates for BioTelemetry, Inc. (BEAT) Decreased by AnalystFY2017 EPS Estimates for BioTelemetry, Inc. (BEAT) Decreased by Analyst
www.americanbankingnews.com - November 10 at 8:34 AM
Pembroke Management, LTD Buys Tucows Inc, Westport Fuel Systems Inc, Paycom Software Inc, Sells ...Pembroke Management, LTD Buys Tucows Inc, Westport Fuel Systems Inc, Paycom Software Inc, Sells ...
www.nasdaq.com - November 9 at 5:39 PM
BioTelemetry, Inc. (BEAT) Expected to Post FY2017 Earnings of $0.74 Per ShareBioTelemetry, Inc. (BEAT) Expected to Post FY2017 Earnings of $0.74 Per Share
www.americanbankingnews.com - November 9 at 8:30 AM
Edited Transcript of BEAT earnings conference call or presentation 7-Nov-17 10:00pm GMTEdited Transcript of BEAT earnings conference call or presentation 7-Nov-17 10:00pm GMT
finance.yahoo.com - November 8 at 7:00 PM
Dougherty & Co Reaffirms Buy Rating for BioTelemetry, Inc. (BEAT)Dougherty & Co Reaffirms Buy Rating for BioTelemetry, Inc. (BEAT)
www.americanbankingnews.com - November 8 at 3:40 PM
BioTelemetry, Inc. Reports Third Quarter 2017 Financial Results ... - GlobeNewswire (press release)BioTelemetry, Inc. Reports Third Quarter 2017 Financial Results ... - GlobeNewswire (press release)
globenewswire.com - November 8 at 5:02 AM
After-Hours Movers 11/07: (ENPH) (COHR) (TTWO) Higher; (RDHL) (LC) (SNAP) Lower (more...)After-Hours Movers 11/07: (ENPH) (COHR) (TTWO) Higher; (RDHL) (LC) (SNAP) Lower (more...)
www.streetinsider.com - November 7 at 11:59 PM
BioTelemetry, Inc. (BEAT) Issues  Earnings ResultsBioTelemetry, Inc. (BEAT) Issues Earnings Results
www.americanbankingnews.com - November 7 at 7:27 PM
ETFs with exposure to BioTelemetry, Inc. : November 7, 2017ETFs with exposure to BioTelemetry, Inc. : November 7, 2017
finance.yahoo.com - November 7 at 6:55 PM
BioTelemetry, Inc. Reports Third Quarter 2017 Financial ResultsBioTelemetry, Inc. Reports Third Quarter 2017 Financial Results
finance.yahoo.com - November 7 at 6:55 PM
BioTelemetry reports 3Q lossBioTelemetry reports 3Q loss
finance.yahoo.com - November 7 at 6:55 PM
BioTelemetry, Inc. (BEAT) Receives Average Recommendation of "Buy" from AnalystsBioTelemetry, Inc. (BEAT) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - November 5 at 1:42 PM
Zacks Investment Research Lowers BioTelemetry, Inc. (BEAT) to Strong SellZacks Investment Research Lowers BioTelemetry, Inc. (BEAT) to Strong Sell
www.americanbankingnews.com - November 2 at 8:33 PM
BioTelemetry, Inc. to Post Q3 2017 Earnings of $0.27 Per Share, Dougherty & Co Forecasts (BEAT)BioTelemetry, Inc. to Post Q3 2017 Earnings of $0.27 Per Share, Dougherty & Co Forecasts (BEAT)
www.americanbankingnews.com - November 2 at 6:24 AM
Jim Cramer Weighs In On BioTelemetry And Kellogg - BenzingaJim Cramer Weighs In On BioTelemetry And Kellogg - Benzinga
www.benzinga.com - October 31 at 10:40 PM
BioTelemetry, Inc. (BEAT) Scheduled to Post Earnings on TuesdayBioTelemetry, Inc. (BEAT) Scheduled to Post Earnings on Tuesday
www.americanbankingnews.com - October 31 at 8:30 PM
BioTelemetry, Inc. to Release Third Quarter 2017 Earnings Results on November 7, 2017 - GlobeNewswire (press release)BioTelemetry, Inc. to Release Third Quarter 2017 Earnings Results on November 7, 2017 - GlobeNewswire (press release)
globenewswire.com - October 30 at 10:56 PM
BioTelemetry, Inc. to Release Third Quarter 2017 Earnings Results on November 7, 2017BioTelemetry, Inc. to Release Third Quarter 2017 Earnings Results on November 7, 2017
feeds.benzinga.com - October 30 at 7:13 PM
$81.43 Million in Sales Expected for BioTelemetry, Inc. (BEAT) This Quarter$81.43 Million in Sales Expected for BioTelemetry, Inc. (BEAT) This Quarter
www.americanbankingnews.com - October 28 at 3:48 AM
Stocks With Rising Relative Strength: BioTelemetryStocks With Rising Relative Strength: BioTelemetry
finance.yahoo.com - October 27 at 6:50 PM

SEC Filings

BioTelemetry (NASDAQ:BEAT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

BioTelemetry (NASDAQ:BEAT) Income Statement, Balance Sheet and Cash Flow Statement

Chart

BioTelemetry (NASDAQ BEAT) Stock Chart for Wednesday, December, 13, 2017

Loading chart…

This page was last updated on 12/13/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.